Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952924006682 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832595734717792256 |
|---|---|
| author | Barbara D. Friedes Amanda M. DiNofia Emma Iannone Yimei Li Susan R. Rheingold Allison Barz Leahy Lisa Wray Colleen Callahan Diane Baniewicz Lauren Vernau Kelly D. Getz Richard Aplenc Shannon L. Maude Stephan A. Grupp Regina M. Myers |
| author_facet | Barbara D. Friedes Amanda M. DiNofia Emma Iannone Yimei Li Susan R. Rheingold Allison Barz Leahy Lisa Wray Colleen Callahan Diane Baniewicz Lauren Vernau Kelly D. Getz Richard Aplenc Shannon L. Maude Stephan A. Grupp Regina M. Myers |
| author_sort | Barbara D. Friedes |
| collection | DOAJ |
| format | Article |
| id | doaj-art-143adbbbadce4bc1b6e898cdadda9841 |
| institution | Kabale University |
| issn | 2473-9529 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Blood Advances |
| spelling | doaj-art-143adbbbadce4bc1b6e898cdadda98412025-01-18T05:04:59ZengElsevierBlood Advances2473-95292025-01-0192354359Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapyBarbara D. Friedes0Amanda M. DiNofia1Emma Iannone2Yimei Li3Susan R. Rheingold4Allison Barz Leahy5Lisa Wray6Colleen Callahan7Diane Baniewicz8Lauren Vernau9Kelly D. Getz10Richard Aplenc11Shannon L. Maude12Stephan A. Grupp13Regina M. Myers14Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; University of Colorado School of Medicine, Aurora, CODivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; University of Colorado School of Medicine, Aurora, CO; Department of Biomedical and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PADepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PADivision of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Correspondence: Regina M. Myers, Children’s Hospital of Philadelphia, Hub for Clinical Collaboration, Office 3545, 3500 Civic Center Blvd, Philadelphia, PA 19104;http://www.sciencedirect.com/science/article/pii/S2473952924006682 |
| spellingShingle | Barbara D. Friedes Amanda M. DiNofia Emma Iannone Yimei Li Susan R. Rheingold Allison Barz Leahy Lisa Wray Colleen Callahan Diane Baniewicz Lauren Vernau Kelly D. Getz Richard Aplenc Shannon L. Maude Stephan A. Grupp Regina M. Myers Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy Blood Advances |
| title | Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy |
| title_full | Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy |
| title_fullStr | Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy |
| title_full_unstemmed | Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy |
| title_short | Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy |
| title_sort | therapies and outcomes following extramedullary relapse of pediatric and young adult all after cd19 car t cell therapy |
| url | http://www.sciencedirect.com/science/article/pii/S2473952924006682 |
| work_keys_str_mv | AT barbaradfriedes therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT amandamdinofia therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT emmaiannone therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT yimeili therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT susanrrheingold therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT allisonbarzleahy therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT lisawray therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT colleencallahan therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT dianebaniewicz therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT laurenvernau therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT kellydgetz therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT richardaplenc therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT shannonlmaude therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT stephanagrupp therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy AT reginammyers therapiesandoutcomesfollowingextramedullaryrelapseofpediatricandyoungadultallaftercd19cartcelltherapy |